Viewing Study NCT03127202


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-01-11 @ 10:40 PM
Study NCT ID: NCT03127202
Status: COMPLETED
Last Update Posted: 2017-04-25
First Post: 2016-03-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Left Ventricular Pacing Vectors Effectiveness to Narrow Phrenic Nerve Stimulation
Sponsor: LivaNova
Organization:

Study Overview

Official Title: Evaluation of Left Ventricular Pacing Vectors Use in Phrenic Nerve Stimulation Management and Left Ventricular Parameters Adjustment
Status: COMPLETED
Status Verified Date: 2017-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ORPHEE
Brief Summary: Evaluation of three left ventricular pacing polarities effectiveness to narrow phrenic nerve stimulation.
Detailed Description: The primary endpoint of the study aims at demonstrating that the three left ventricular polarities in the Cardiac Resynchronisation Therapy-Defibrillator could bypass phrenic nerve stimulation at least in 90% of implants.

Success was defined as an absence of phrenic nerve stimulation (threshold \> 7V) or in case of phrenic nerve stimulation occurrence (threshold \< 7V), as the resolution of the phrenic nerve stimulation by reprogramming one of the 3 left ventricular pacing polarities available in the device : left ventricular tip- left ventricular ring (bipolar), left ventricular tip- right ventricular ring (pseudo-bipolar) and left ventricular ring-right ventricular coil.

Any occurrence of phrenic nerve stimulation without resolution by reprogramming was considered as a failure.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: